Clinical Observation of Azithromycin Treatment of Mycoplasma Pneumonia in Children in Comparison with Treatment of Erythromycin
Yan Wang
Abstract
Yan Wang
Abstract
Objective To evaluate the curative effect and security of azithromycin sequential therapy on mycoplasma pneumonia(MP) in children,and campare the effect of azithromycin and erythromycin.Methods On serum examination,the 120 cases of pneumonia were mycoplasma antibody positive,and were randomly divided into two groups.with 60 patients each.The treatment group were treated with azithromycin,while control group were treated with erythromycin.The symptoms,change of the lung signs and adverse reactions were observed before and after treatment.Results The total effective rates in treatment group and control group were 90.0% and 86.7%.The comparison of two groups was not statistically significant difference;the adverse reaction rates in treatment group and control group were 25% and 70%,and obviously that of the treatment group was less than the control group.Conclusion Azithromycin sequential therapy on mycoplasma pneumoniae in children is better than erythromycin,with better curative effect and fewer side effects,and is worth the clinical promotion and application.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the curative effect and security of azithromycin sequential therapy on mycoplasma pneumonia(MP) in children,and campare the effect of azithromycin and erythromycin.Methods On serum examination,the 120 cases of pneumonia were mycoplasma antibody positive,and were randomly divided into two groups.with 60 patients each.The treatment group were treated with azithromycin,while control group were treated with erythromycin.The symptoms,change of the lung signs and adverse reactions were observed before and after treatment.Results The total effective rates in treatment group and control group were 90.0% and 86.7%.The comparison of two groups was not statistically significant difference;the adverse reaction rates in treatment group and control group were 25% and 70%,and obviously that of the treatment group was less than the control group.Conclusion Azithromycin sequential therapy on mycoplasma pneumoniae in children is better than erythromycin,with better curative effect and fewer side effects,and is worth the clinical promotion and application.
Key concepts: Azithromycin, Erythromycin, Medicine, Mycoplasma pneumonia, Internal medicine, Adverse effect, Pneumonia, Mycoplasma pneumoniae